NCT00113802 2021-08-19Study of Epratuzumab (hLL2) in Patients With Waldenstrom's MacroglobulinemiaGilead SciencesPhase 2 Terminated31 enrolled
NCT00579111 2016-05-04Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)Baylor College of MedicinePhase 1/2 Terminated4 enrolled 8 charts